158 related articles for article (PubMed ID: 29022493)
1. Immunonutrition before esophagectomy: Impact on immune surveillance mechanisms.
Scarpa M; Kotsafti A; Fassan M; Scarpa M; Cavallin F; Nardi T; Pinto E; Alfieri R; Cagol M; Agostini M; Rugge M; Castagliuolo I; Castoro C
Tumour Biol; 2017 Oct; 39(10):1010428317728683. PubMed ID: 29022493
[TBL] [Abstract][Full Text] [Related]
2. Preoperative immunonutrition decreases postoperative complications by modulating prostaglandin E2 production and T-cell differentiation in patients undergoing pancreatoduodenectomy.
Aida T; Furukawa K; Suzuki D; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
Surgery; 2014 Jan; 155(1):124-33. PubMed ID: 24589090
[TBL] [Abstract][Full Text] [Related]
3. Enteral immunonutrition versus enteral nutrition for patients undergoing esophagectomy: a randomized controlled trial.
Li XK; Cong ZZ; Wu WJ; Xu Y; Zhou H; Wang GM; Qiang Y; Luo LG; Shen Y
Ann Palliat Med; 2021 Feb; 10(2):1351-1361. PubMed ID: 33222455
[TBL] [Abstract][Full Text] [Related]
4. Preoperative oral supplementation support in patients with esophageal cancer.
Kubota K; Kuroda J; Yoshida M; Okada A; Deguchi T; Kitajima M
J Nutr Health Aging; 2014 Apr; 18(4):437-40. PubMed ID: 24676327
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer undergoing irreversible electroporation (IRE).
Martin RC; Agle S; Schlegel M; Hayat T; Scoggins CR; McMasters KM; Philips P
Eur J Surg Oncol; 2017 Apr; 43(4):772-779. PubMed ID: 28162818
[TBL] [Abstract][Full Text] [Related]
6. The impact of preoperative immunonutrition and other nutrition models on tumor infiltrative lymphocytes in colorectal cancer patients.
Caglayan K; Oner I; Gunerhan Y; Ata P; Koksal N; Ozkara S
Am J Surg; 2012 Oct; 204(4):416-21. PubMed ID: 23010614
[TBL] [Abstract][Full Text] [Related]
7. Multicentre factorial randomized clinical trial of perioperative immunonutrition versus standard nutrition for patients undergoing surgical resection of oesophageal cancer.
Mudge LA; Watson DI; Smithers BM; Isenring EA; Smith L; Jamieson GG;
Br J Surg; 2018 Sep; 105(10):1262-1272. PubMed ID: 29999517
[TBL] [Abstract][Full Text] [Related]
8. Immunonutrition in patients undergoing esophageal cancer resection.
Mudge L; Isenring E; Jamieson GG
Dis Esophagus; 2011 Apr; 24(3):160-5. PubMed ID: 20946133
[TBL] [Abstract][Full Text] [Related]
9. Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial.
Talvas J; Garrait G; Goncalves-Mendes N; Rouanet J; Vergnaud-Gauduchon J; Kwiatkowski F; Bachmann P; Bouteloup C; Bienvenu J; Vasson MP
Clin Nutr; 2015 Oct; 34(5):810-7. PubMed ID: 25575640
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of perioperative immunonutrition for patients with esophageal cancer.
Takeuchi H; Ikeuchi S; Kawaguchi Y; Kitagawa Y; Isobe Y; Kubochi K; Kitajima M; Matsumoto S
World J Surg; 2007 Nov; 31(11):2160-7. PubMed ID: 17876664
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
[TBL] [Abstract][Full Text] [Related]
12. Additional effect of perioperative, compared with preoperative, immunonutrition after pancreaticoduodenectomy: A randomized, controlled trial.
Miyauchi Y; Furukawa K; Suzuki D; Yoshitomi H; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M
Int J Surg; 2019 Jan; 61():69-75. PubMed ID: 30540966
[TBL] [Abstract][Full Text] [Related]
13. Preoperative noninvasive EUS evaluation in patients with esophageal cancer considered for esophagectomy.
Gheorghe C; Stanescu C; Gheorghe L; Bancila I; Herlea V; Becheanu G; Voinea D; Iacob R; Lupescu I; Anghel R; Croitoru A; Popescu I
J Gastrointestin Liver Dis; 2006 Jun; 15(2):137-41. PubMed ID: 16802008
[TBL] [Abstract][Full Text] [Related]
14. The port site recurrence after a thoracoscopic and video-assisted esophagectomy for advanced esophageal cancer.
Yamamoto S; Kawahara K; Maekawa T; Shiraishi T; Shirakusa T
J Thorac Oncol; 2009 Jan; 4(1):131-4. PubMed ID: 19096321
[TBL] [Abstract][Full Text] [Related]
15. Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer.
Maruyama T; Mimura K; Izawa S; Shiba S; Watanabe M; Kawaguchi Y; Fujii H; Kono K
Nutrition; 2011 Feb; 27(2):146-52. PubMed ID: 21215924
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition.
Okamoto Y; Okano K; Izuishi K; Usuki H; Wakabayashi H; Suzuki Y
World J Surg; 2009 Sep; 33(9):1815-21. PubMed ID: 19629583
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery.
Sultan J; Griffin SM; Di Franco F; Kirby JA; Shenton BK; Seal CJ; Davis P; Viswanath YK; Preston SR; Hayes N
Br J Surg; 2012 Mar; 99(3):346-55. PubMed ID: 22237467
[TBL] [Abstract][Full Text] [Related]
20. Significance of Microscopically Incomplete Resection Margin After Esophagectomy for Esophageal Cancer.
Markar SR; Gronnier C; Duhamel A; Pasquer A; Théreaux J; Chalret du Rieu M; Lefevre JH; Turner K; Luc G; Mariette C;
Ann Surg; 2016 Apr; 263(4):712-8. PubMed ID: 26135681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
